Rapid Detection of Clostridium difficile Toxins in Serum by Raman Spectroscopy

• Published in: The Journal of surgical research 2018-12, Vol.232, p.195-201
• Main Authors: Koya, Satya Kiran, Brusatori, Michelle, Martin, Jonathan V., Yurgelevic, Sally, Huang, Changhe, Liberati, David M., Auner, Gregory W., Diebel, Lawrence N.
• Format: Article
• Language: English
• Subjects: Bacterial Proteins - blood; Bacterial Toxins - blood; Clostridium difficile toxin A and B; Diagnostic test; Enterotoxins - blood; Humans; Least-Squares Analysis; Raman spectroscopy; Rapid detection; Spectrum Analysis, Raman - methods; Systemic CDI
• ISSN: 0022-4804; 1095-8673
• DOI: 10.1016/j.jss.2018.06.031

Clostridium difficile infection (CDI) is due to the effects of toxins, toxin A and toxin B on the host. Severe CDI is associated with systemic signs of infection. Animal models of CDI demonstrate a strong correlation between systemic toxemia and the occurrence of severe disease. However, current technologies have low sensitivity to detect C difficile toxemia in human subjects. Raman spectroscopy (RS) is an upcoming technology that is used to detect bacteria and their toxins. We speculate that RS may be a sensitive method to detect clinically relevant concentrations of C difficile toxins in serum. Serum samples were spiked with varying concentrations of toxin A, toxin B, and both. RS was performed on an air-dried serum drop that was placed on a mirror-polished stainless steel slide. Raman spectra were obtained, background corrected, vector normalized, and analyzed by Partial Least Square Linear Discriminant Analysis and Support Vector Machine for Classification. Model accuracy was measured by cross-validation and bootstrap methods. Toxin-spiked sera of various concentrations (1 ng/mL, 1 pg/mL, and 0.1 pg/mL) were distinguished from control serum 100% with cross-validation error rate ranging from 0% to 18% and bootstrap error rate ranging from 0% to 12% for various concentrations. The sensitivity ranged from 87% to 100% and specificity ranged from 77% to 100% for various concentrations of toxin-spiked serum. We conclude that RS may be a sensitive method to detect clinically relevant concentrations of C difficile toxins in serum and thus to help diagnose severe CDI in patients in real-time at the point of care.